In addition, inhibition of ADA prevents postischemic heart injury by blocking of sequential substrate formation for xanthine oxidase which generates reactive oxygen species in the heart [13], and recent studies have reported the potential of inhibiting ADA activity during antitumor therapy, revealing that it can suppress the progression of breast cancer cells [14]. Here, ADA is linked to breast carcinoma.